| Literature DB >> 35908822 |
Kristin Flemons1, Barry Baylis2, Aurang Zeb Khan3, Andrew W Kirkpatrick4, Ken Whitehead5, Shahab Moeini5, Allister Schreiber5, Stephanie Lapointe5, Sara Ashoori5, Mishal Arif5, Byron Berenger6, John Conly7, Wade Hawkins8.
Abstract
BACKGROUND: Health care inequity in remote and rural Indigenous communities often involves difficulty accessing health care services and supplies. Remotely Piloted Aircraft Systems, or drones, offer a potentially cost-effective method for reducing inequity by removing geographic barriers, increasing timeliness, and improving accessibility of supplies, equipment, and remote care.Entities:
Keywords: Drones; Health care access; Remote ultrasound; Remotely piloted aircraft systems; SARS-CoV-2
Mesh:
Substances:
Year: 2022 PMID: 35908822 PMCID: PMC9329072 DOI: 10.1016/j.ajic.2022.03.004
Source DB: PubMed Journal: Am J Infect Control ISSN: 0196-6553 Impact factor: 4.303
Drone fleet development details
| Endurance | Short Endurance | Medium Endurance | High Endurance |
| Payload | Low Payload | Medium Payload | High Payload |
| RPAS examples | DJI Mavic Enterprise | DJI Matrice 300 | SwissDrone SDO 50 V2 |
| Operating Temperature | -10°C to 40°C | -20°C to 40°C | -25° to 40 °C |
| Operating Range | 8 km | Matrice 300-15 km | SwissDrone – 300 km |
| VLOS/BVLOS testing completed | Flown within VLOS and EVLOS | Flown within VLOS and EVLOS | VLOS, EVLOS and BVLOS |
| Payload delivery systems tested | Fixed mounted payload - neoprene sleeve | Fixed mounted payload and winch system | Fixed mounted payload |
| Unit Cost | $2,000 | $7,000 - $15,000 | $200,000 - $600,000 |
Fig 1Winch and fixed mount payload systems.
Results of COVID-19 test kits flown via drone versus controls
| E gene | MS2 | |||||
|---|---|---|---|---|---|---|
| Media | Copies/mL of E gene RNA or MS2 dilution | Control (no flight) Sample Ct | Drone Sample Ct | Control (no flight) Sample Ct | Drone Sample Ct | |
| Saline | 3.31x107 E gene RNA | 25.14 | 22.26 | Target not Included | ||
| Saline | 3.31x106 E gene RNA | 27.82 | 26.51 | |||
| Saline | 3.31x105 E gene RNA | 30 | 28.94 | |||
| UTM | 102 MS2 phage | Target not Included | 19.71 | 20.06 | ||
| UTM | 103 MS2 phage | 23.44 | 23.38 | |||
| UTM | 104 MS2 phage | 26.83 | 26.95 | |||
| Saline in Duplicate | 3.31x106 E gene RNA + 101 MS2 phage | 24.96 | 25 | 16.38 | 16.68 | |
| 24.98 | 24.92 | 16.63 | 16.3 | |||
| Saline in Duplicate | 3.31x104 E gene RNA + 103 MS2 phage | 33.13 | 33.51 | 23.3 | 23.63 | |
| 34.39 | 34.58 | 23.55 | 23.67 | |||
Fig 2Map of flight path for delivery simulation mission.